Home » Newsletters » BioWorld Science

BioWorld Science

May 2, 2003

View Archived Issues

New data on the effects of intracavernosal administration of PDE5 inhibitors

Zoledronic acid reduces skeletal morbidity associated with prostate cancer

Improved quality of life with intermittent androgen deprivation after radical prostatectomy

Praecis achieves goals in first quarter of 2003

Pravastatin reduces disease activity in mice with dextran sulfate-induced colitis

Entry inhibitors and efficacy in preventing HIV transmission

New RXR agonists and their use in diabetes and obesity disclosed by GSK

Further research on tyrosine kinase inhibitors reported by Allergan

Novel antibacterial oxazolidinones developed by Merck and Kyorin

Novel agents for enhancing DNA-damaging activity

BMS researchers identify new anti-HCV NS5B inhibitors

New antitumor camptothecins identified by Indian researchers

French team prepares and tests new agents with hypoglycemic and lipid lowering activity

Novel muscarinic M1 agonists and their use in cognition disorders described by Lilly

Merck claims androgen receptor modulators for use in bone disorders

Prous Science announces the publication of state-of-the-art review: dermatomyositis

Ranbaxy updates clinical progress in first quarter

Johnson & Johnson completes merger with Scios

Additional data and analyses submitted to FDA in support of Risperdal Consta

Patent broadens coverage of Avant's CETP vaccine technology

Additional analysis of TP-10 phase II data reveals benefit in males

MRI plus Combidex aids in assessing residual and primary brain, head and neck tumors

Early termination of FTC review for Axert rights

Pilot study for PTI-901 in IBS completes enrollment

Approval for new Zosyn dosing regimen

CPMP adopts negative opinion for Serostim for AIDS-related wasting syndrome

Travatan indication extended for first-line therapy for ocular hypertension

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...